Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
- 1 December 1993
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 169 (6) , 1536-1539
- https://doi.org/10.1016/0002-9378(93)90431-h
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Dehydroepiandrosterone (DHEA) Levels in Patients with Prostatic Cancer, Heart Diseases and under Surgery StressExperimental and Clinical Endocrinology & Diabetes, 1992
- Obesity in the Dog: Role of the Adrenal Steroid Dehydroepiandrosterone (DHEA)Journal of Nutrition, 1991
- Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopauseMaturitas, 1989
- DIVERGENT CORRELATIONS OF CIRCULATING DEHYDROEPIANDROSTERONE SULFATE AND TESTOSTERONE WITH INSULIN LEVELS AND INSULIN RECEPTOR BINDING.Journal of Clinical Endocrinology & Metabolism, 1988
- Dehydroepiandrosterone Reduces Serum Low Density Lipoprotein Levels and Body Fat but Does not Alter Insulin Sensitivity in Normal Men*Journal of Clinical Endocrinology & Metabolism, 1988
- Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosteroneAdvances in Enzyme Regulation, 1987
- Declining Adrenal Androgens: An Association with Bone Loss in Aging WomenExperimental Biology and Medicine, 1987
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986
- Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic miceDiabetes, 1982
- Decline of Adrenal Androgen Production as Measured by Radioimmunoassay of Urinary Unconjugated DehydroepiandrosteroneJournal of Clinical Endocrinology & Metabolism, 1978